Open AccessAssessing Knowledge of HIV Vaccines and Biomedical Prevention Methods Among Transgender Women in the New York City Tri-State Area
Author(s) -
Nicholas Kenji Taylor,
Maria Young,
Van Don Williams,
Jorge Benitez,
DaShawn Usher,
Scott M. Hammer,
HongVan Tieu,
Magdalena E. Sobieszczyk
Publication year - 2020
Publication title -
transgender health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.242
H-Index - 20
eISSN - 2688-4887
pISSN - 2380-193X
DOI - 10.1089/trgh.2019.0049
Subject(s) - transgender , psychosocial , medicine , psychological intervention , pre exposure prophylaxis , family medicine , gerontology , feeling , human immunodeficiency virus (hiv) , men who have sex with men , psychology , nursing , psychiatry , social psychology , syphilis , psychoanalysis
Purpose: To lower the HIV risk of transgender women, it is imperative to understand their unique HIV prevention needs and design biomedical prevention interventions that are responsive to the psychosocial, behavioral, and clinical needs of these communities. Preventive HIV vaccines are an important modality under investigation in diverse study participants. We sought to assess the knowledge of HIV vaccine research and the most common barriers and facilitators to participation in HIV vaccine studies among HIV-negative transgender women living in New York City. Methods: Six focus groups were conducted among 29 participants recruited in the New York City tri-state area from December 2014 to July 2015. Prefocus group quantitative questionnaire assessed demographic, behavioral information, knowledge of preventive vaccine research, and reasons for potential participation in prevention studies. Results: Median age of participants was 29 years and 41.4% identified as white. Over half of participants have heard of preventive vaccine research and majority indicated that an important factor in participating in HIV prevention research is to help the community collective effort. Key barriers that emerged were fear of side effects, feelings of exclusion from biomedical research. Facilitators to participation in prevention studies included trusting relationships with providers. Conclusions: These barriers and facilitators are important to consider in the design of studies inclusive of trans communities and transgender-specific prevention strategies. Barriers may be overcome by disseminating accurate information via social media or health providers.